An AI-guided method improves intra-arterial therapy by mapping all tumor-feeding arteries to enhance delivery accuracy in malignant brain tumor treatment.
Key Details
- 1Technique was developed and tested by MD Anderson Cancer Center researchers.
- 2AI identifies all blood vessels feeding a brain tumor using imaging.
- 3Allows for multi-pedicle, not just single-artery, delivery of intra-arterial therapy.
- 4Multi-pedicle approach covered >85% of tumors vs. <65% with single-pedicle infusion.
- 5Tested in 3 patients, shown to reduce off-target therapy and enable potential repeatability.
- 6Presented at the SNIS 23rd Annual Meeting; further studies are needed for outcomes.
Why It Matters
Precise targeting of tumor vasculature could optimize therapeutic exposure and minimize side effects in difficult-to-treat brain tumors. This AI-driven approach exemplifies the evolving role of advanced imaging and AI in interventional radiology and neuro-oncology innovation.
Source
EurekAlert
Related News
•EurekAlert
New G-AUDIT Tool Detects Hidden Bias in Medical AI Training Data
Johns Hopkins and FDA researchers unveil G-AUDIT, a tool to identify hidden biases in medical AI datasets before model training.
•EurekAlert
AI-Driven Bone Marrow Mapping Tool Improves Blood Cancer Assessment
Weill Cornell Medicine develops an AI tool to score and track disease severity in blood cancer from bone marrow imaging.
•EurekAlert
Bio-Inspired E-Skin Achieves High-Fidelity Signal Capture and ML-Controlled Teleoperation
Researchers develop a breathing, stretchable e-skin for robust biosignal acquisition and AI-driven teleoperation, outperforming conventional electrodes.